Show an ad over header. AMP

I am the FIRST!!!

Tim Kaine, Susan Collins pitch Senate colleagues on censuring Donald Trump

Sens. Tim Kaine and Susan Collins are privately pitching their colleagues on a bipartisan resolution censuring former President Trump, three sources familiar with the discussions tell Axios.

Why it matters: Senators are looking for a way to condemn Trump on-the-record as it becomes increasingly unlikely Democrats will obtain the 17 Republican votes needed to gain a conviction in his second impeachment.


What we're hearing: Some Democrats are interested only if at least 10 GOP senators publicly commit to a censure, thus ensuring the 60-vote margin needed to pass major legislation in the chamber.

  • It's still unclear whether a resolution would be in lieu of or come after a trial.

Driving the news: Kaine (D-Va.) and Collins (R-Maine) have been interested in a censure resolution for weeks now and have discussed it on multiple occasions.

  • But the bipartisan discussions among senators grew more earnest after 45 Republicans voted today in favor of a motion to dismiss the trial because Trump is now out of office.
  • The vote was a clear indication he won't be convicted.

Between the lines: In some ways a censure vote could be more difficult for Republicans, because they can't rely on the argument that a resolution is unconstitutional — like they are for an impeachment conviction.

  • It would also be a history-making vote. No other president has been censured after leaving office.

What they're saying: "I think it's pretty obvious from the vote today, that it is extraordinarily unlikely that the president will be convicted. Just do the math," Collins told reporters Tuesday afternoon.

  • Kaine has said he wants to do whatever possible to keep the focus on the Biden-Harris agenda and COVID-19 relief, so he supports a speedy trial or alternate way to hold Trump accountable.

regular 4 post ff

infinite scroll 4 pff

Moderna is Americans' third-favorite company this year

Data: Harris Poll; Chart: Danielle Alberti/Axios

America's affections have shifted away from the companies that helped us manage pandemic life and toward the vaccine manufacturers that are helping to end it.

Driving the news: Moderna and Pfizer shot up the ranks this year in the Axios/Harris 100, our annual survey of corporate reputations. Moderna is Americans' third-favorite company this year, and Pfizer came in at seventh — up from No. 61 a year ago.

Keep reading...Show less

Podcast: The art and business of political polling

The election is just eight days away, and it’s not just the candidates whose futures are on the line. Political pollsters, four years after wrongly predicting a Hillary Clinton presidency, are viewing it as their own judgment day.

Axios Re:Cap digs into the polls, and what pollsters have changed since 2016, with former FiveThirtyEight writer and current CNN politics analyst Harry Enten.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;